Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pediatric thyroid cancer.

Devendra A Chaukar1, Venkatesh Rangarajan, Narendra Nair

  • 1Department of Head and Neck surgery, Tata Memorial Hospital, Ernest Borges Road, Parel, Mumbai, India. dchaukar@rediffmail.com

Journal of Surgical Oncology
|October 19, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Persistent Fluorodeoxyglucose Uptake on Post-Definitive Radiotherapy PET/CT Evaluation Predicts Poor Survival in Pediatric Metastatic Ewing Sarcoma: A Single-Center Cohort Study.

Cancer medicine·2026
Same author

Geriatric Oncology multidomain intervention study to prevent Cognitive impairment among older Indian patients with cancer receiving chemotherapy: a multicentric randomised controlled trial (GOCog).

BMC geriatrics·2026
Same author

Artificial Intelligence Assisted <sup>18</sup>F-FDG PET Radiomics in Classifying Histological Subtypes of Lung Cancer: Systematic Review and Meta-analysis.

Nuclear medicine and molecular imaging·2026
Same author

PSA and PSMA Kinetics After PSMA-PET and MR Guided Prostate Stereotactic Body Radiation Therapy With Focal Boost: Results From the Phase 2 PROBE Trial.

International journal of radiation oncology, biology, physics·2026
Same author

PReCedeNT trial: Phase III randomized-controlled trial of Lutetium - 177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) plus Chemotherapy versus PRRT alone in FDG-avid, Well-differentiated Gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

BMC cancer·2025
Same author

First-in-India experience with 90Y-BhabhaSphere: an indigenous 90Y-TheraSphere biosimilar for transarterial radioembolization of hepatic malignancies.

The British journal of radiology·2025

Pediatric thyroid cancer, often advanced at diagnosis, shows an excellent prognosis. Total thyroidectomy and radioactive iodine are recommended due to high rates of pulmonary metastases in children.

Area of Science:

  • Pediatric Oncology
  • Endocrinology
  • Surgical Oncology

Background:

  • Treatment strategies for pediatric thyroid cancer remain controversial.
  • The optimal extent of surgery and the role of postoperative radioactive iodine therapy are not well-defined.
  • Understanding the behavior and management of pediatric thyroid cancers is crucial.

Purpose of the Study:

  • To analyze the clinical behavior of pediatric thyroid cancers.
  • To evaluate the effectiveness of current management strategies.
  • To determine optimal treatment approaches for improved patient outcomes.

Main Methods:

  • Retrospective analysis of 83 pediatric thyroid cancer patients diagnosed between 1964 and 2000.
  • Survival analysis included 57 patients with adequate follow-up.

Related Experiment Videos

  • Epidemiological data analyzed from an additional 26 patients.

    • Main Results:

    • Papillary carcinoma was the predominant histology (57%).
    • Cervical lymphadenopathy was a common presentation (57.8%), associated with a higher incidence of pulmonary metastases (P=0.037).
    • 19.2% presented with pulmonary metastases, with some detected only by radioiodine scan.

    Conclusions:

    • Pediatric thyroid cancer demonstrates an excellent prognosis despite advanced stage at presentation.
    • High incidence of pulmonary metastases supports total thyroidectomy and radioactive iodine therapy.
    • Recommended management includes total thyroidectomy and radioactive iodine for pediatric thyroid cancer.